Form 4: Elanco Animal Health Director Deborah Kochevar Receives Stock Award

Elanco Animal Health director Deborah Kochevar received 18,169 shares of common stock as part of an annual equity award.

Summary

• Deborah Kochevar, a director at Elanco Animal Health, received 18,169 shares of common stock on November 29, 2024.
• This stock grant was part of an annual equity award for non-employee members of the Board of Directors.
• Following this transaction, Ms. Kochevar directly owns 79,400 shares of Elanco common stock.
• The shares were granted at a price of $0.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock grants to a board member, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The equity award aligns the interests of the non-employee directors with the company's performance.
• The grant of shares increases Ms. Kochevar's stake in the company.

Industry Context

This is a standard practice for public companies to grant equity to non-employee board members as part of their compensation.

Comparison to Industry Standards

• Granting stock to board members is a common practice across publicly traded companies, including those in the animal health sector.
• Companies like Zoetis and IDEXX Laboratories also use equity grants as part of their board compensation packages.
• The size of the grant is likely determined by the company's compensation policy and the director's role.

Stakeholder Impact

• The stock grant increases the alignment of interests between the director and shareholders.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco Animal Health, Deborah Kochevar, stock grant, equity award, director, Form 4, insider trading